Skip to content

Clinical trials

Completed Phase 2 Psychotic Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Phase: Phase 2 Status: Completed Clear all

92 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20023
20032
20047
20059
20066
20077
20083
20094
20103
20116
20125
20132
20146
20155
20162
20172
20182
20193
20205
20222
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed92

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yale University4
ACADIA Pharmaceuticals Inc.3
China Medical University Hospital3
Mclean Hospital3
NYU Langone Health3
Pakistan Institute of Living and Learning3
Solvay Pharmaceuticals3
The Alfred3
University of California, San Diego3
University of Colorado, Denver3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders92
Schizophrenia67
Bipolar Disorder18
Mental Disorders11
Hallucinations6
Parkinson Disease5
Major Depressive Disorder4
Mood Disorders4
Anxiety Disorders3
Dyskinesias3

Trials

Showing 1 to 25 of 92. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.